PharmaEssentia Corporation (TPE:6446)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
508.00
+11.00 (2.21%)
May 14, 2025, 1:30 PM CST

PharmaEssentia Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
165,522204,725114,578143,84078,06524,709
Upgrade
Market Cap Growth
61.69%78.68%-20.34%84.26%215.94%2.44%
Upgrade
Enterprise Value
144,438184,91594,836140,32277,60321,027
Upgrade
Last Close Price
497.00615.00346.00477.00289.3492.63
Upgrade
PE Ratio
42.5969.04----
Upgrade
Forward PE
24.4141.3631.8969.03--
Upgrade
PS Ratio
14.6021.0322.4449.91118.9144.34
Upgrade
PB Ratio
5.687.454.7811.8518.376.30
Upgrade
P/TBV Ratio
5.747.534.8412.0819.506.68
Upgrade
P/FCF Ratio
-121.51----
Upgrade
P/OCF Ratio
-80.38----
Upgrade
EV/Sales Ratio
12.7419.0018.5848.69118.2137.73
Upgrade
EV/EBITDA Ratio
45.58100.14----
Upgrade
EV/EBIT Ratio
51.15106.51----
Upgrade
EV/FCF Ratio
48.69109.75----
Upgrade
Debt / Equity Ratio
0.030.040.050.130.130.17
Upgrade
Debt / EBITDA Ratio
0.310.47----
Upgrade
Debt / FCF Ratio
0.330.57----
Upgrade
Asset Turnover
0.380.330.240.270.110.13
Upgrade
Inventory Turnover
0.950.860.480.830.601.15
Upgrade
Quick Ratio
8.499.349.864.372.803.37
Upgrade
Current Ratio
9.079.9410.645.243.493.82
Upgrade
Return on Equity (ROE)
14.56%11.54%-3.46%-16.77%-68.81%-63.10%
Upgrade
Return on Assets (ROA)
5.86%3.72%-5.61%-11.77%-30.08%-25.26%
Upgrade
Return on Capital (ROIC)
6.34%4.05%-6.16%-13.71%-37.72%-29.60%
Upgrade
Return on Capital Employed (ROCE)
9.40%6.10%----
Upgrade
Earnings Yield
2.36%1.45%-0.54%-0.96%-3.60%-7.88%
Upgrade
FCF Yield
1.79%0.82%-1.74%-1.26%-3.24%-6.22%
Upgrade
Dividend Yield
0.22%0.18%----
Upgrade
Buyback Yield / Dilution
-1.13%-3.59%-13.47%-9.24%-7.39%-10.55%
Upgrade
Total Shareholder Return
-0.90%-3.41%-13.47%-9.24%-7.39%-10.55%
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.